TWST News and Press, Twist Bioscience Corporation From 12/13/22

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Twist To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - December 13, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, i...

NEW YORK, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against PROG Holdings, Inc. (NYSE: PRG), Fox Corporation (NASDAQ: FOX, FOXA), Instil Bio, Inc. (NASDAQ: TIL), and Twist Bioscience Co...

SAN FRANCISCO, CA / ACCESSWIRE / December 8, 2022 / Hagens Berman urges Twist Bioscience Corporation (NASDAQ:TWST) investors who suffered significant losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/TWST Contact An Attorney Now: TWST@hbsslaw.com 844-916-089...

San Francisco, California--(Newsfile Corp. - December 1, 2022) - Hagens Berman urges Twist Bioscience Corporation (NASDAQ: TWST) investors who suffered significant losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/TWST Contact An Attorney Now: TWST@hbsslaw.c...

NEW YORK, NY / ACCESSWIRE / November 25, 2022 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ:TWST). If you suffered losses exceeding $50,000 investing in Twist sto...

Company to host investors at the Factory of the Future on November 29 Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D....

-- Record revenue of $203.6 million in Fiscal 2022; Increase of 54% over $132.3 million in Fiscal 2021 – -- Orders increased to $226 million in Fiscal 2022; Increase of 42% over $160 million in Fiscal 2021 -- — Expect revenue in the range of $261 million to $269 mi...

Shares of Twist Bioscience (NASDAQ: TWST) were crashing this week, plunging 37.2% as of the market close on Thursday, according to data provided by S&P Global Market Intelligence . The steep decline came after Scorpion Capital announced on Tuesday that it was short-selling t...

A day after synthetic biology and genomics company Twist Bioscience (NASDAQ: TWST) saw its shares rise 16.1%, they did a U-turn, falling 19.92% on Tuesday. The stock nearly matched its 52-week low and is a long way from its 52-week high. A report issued Tuesday by Scorpion Capit...

Twist to report fiscal Q4 and full year 2022 financial results before market Friday, November 18, and host a conference call at 8:00 a.m. Eastern Time Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-qualit...